CSI Market
Sign In | Register

Biolife Solutions Inc (BLFS) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BLFS Annual Cash Flow →
A period-by-period view of cash flow from Biolife Solutions Inc to Jun 30 2025 helps clarify how Jun 30 2026's cash position has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income46.29
Depreciation & amortization0.79
Amortization of Other Assets0.24
Increase (Decrease) in Deferred Revenue0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories5.44
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation8.66
Noncash Contribution Expense0.00
Foreign Currency Transaction Gain (Loss), Unrealized0.00
Accrued Interest Related Parties-
Deconsolidation Gain Or Loss Amount-
Write Off Of Deferred Debt Issuance Cost-
Writeoff Of Deferred Financing Costs-
Amortization Of Deferred Rent-
Amortization Of Operating Lease Liability-
Noncash Lease Expense-0.19
Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss-
Gain Loss On Disposition Of Assets Held For Rent-
Gain Loss On Acquisition Of Business-
Increase Decrease In Warranty Liability-
Increase Decrease In Warranty Liability-
Increase Decrease In Warranty Liability-
Increase Decrease In Warranty Liability-
Intangible Asset Impairment-
Increase Decrease In Equity Securities Fv Ni-
Payments For Settlement Escrow-
Warranty Liability-
Amortization Of Intangible Assets Consolidated Basis0.33
Debt Securities Available For Sale Unrealized Gain Loss-0.25
Increase Decrease In Prepaid Expense Other Current Assets And Long Term Deposits3.22
Income taxes0.00
Gain (Loss) on Investments0.00
Increase (Decrease) in Accounts Receivable2.70
Increase (Decrease) in Accounts Payable0.84
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-5.16
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.00
Other Working Capital0.03
Other Noncash Income (Expense)0.00
Other net0.20
Payments for (Proceeds from) Other Operating Activities-54.16
Discontinued operations0.00
Net Cash flow from Operating Activities5.86
Investing Activities
Capital Expenditures-1.33
Sale of Capital Items0.00
Proceeds from Sale of Available-for-sale Securities, Debt4.69
Payments to Acquire Available-for-sale Securities, Debt-35.36
Real Estate Investments0.00
Payments To Acquire Assets Held For Rent-
Payments To Acquire Investments In Non Marketable Equity Securities And Available For Sale Debt Securities-
Business Combination Consideration Transferred Equity Interests Issued And Issuable-
Business Combination Consideration Transferred Equity Interests Issued And Issuable-
Business Combination Consideration Transferred Equity Interests Issued And Issuable-
Business Combination Consideration Transferred Equity Interests Issued And Issuable-
Business Combination Consideration Transferred Equity Interests Issued And Issuable-
Payments From Divestiture Of Businesses-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire in Process Research and Development0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses0.00
Accounts payable0.00
Payments to Acquire Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net28.43
Discontinued operations0.00
Net Cash Flow from Investing Activities-3.41
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-5.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.19
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-6.68
Other net0.00
Proceeds From Exercise Of Common Stock Options And Warrants-
Payments On Equipment Financing-
Right Of Use Asset Obtained In Exchange For Finance Lease Liability-
Reclassification Of Property And Equipment To Assets Held For Rent-
Reclassification Of Warrant Liabilities To Equity Upon Exercise-
Capital Expenditures Incurred But Not Yet Paid0.06
Stock Issued-
Registration Filings Fees-
Proceeds From Repayments Of Financed Insurance Premium-
Proceeds From Financed Insurance Premium-
Repayments Of Financed Insurance Premium-
Payments of Ordinary Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-11.49
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow4.53
Total Cash Flow-9.04
4 historic quarters locked

Sign in to unlock the full Biolife Solutions Inc cash flow history.

Sign In Create Free Account

About Biolife Solutions Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-26-054355

Figures are derived from filed reports and may be restated. Historical data is subject to revision.